Combined Effect of Sarcopenia and Impaired Respiratory Function on All‐Cause Death: A Nationwide Cohort Study
Journal of Cachexia, Sarcopenia and Muscle · 2026-04 · 17 (2)
DOI: 10.1002/jcsm.70275 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 05.04.2026. Verfasst von Chutao Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Shantou Central Hospital, Shantou, Guangdong, China. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Zhongnanshan Medical Foundation of Guangdong, Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province.
Abstract (Originalsprache)
Background
Respiratory fitness and sarcopenia status have been reported to be cross‐sectionally linked with each other and increase mortality risk. However, little is currently known regarding the connection between impaired respiratory function and sarcopenia and their joint effect on future death risk.
Methods
This study included 12 027 participants (50.8% were women; mean [SD] age, 58.9 [9.3] years) from a nationwide, prospective cohort in China (China Health and Retirement Longitudinal Study). Respiratory function was assessed by peak expiratory flow (PEF). Sarcopenia status was assessed according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Time‐to‐event survival analyses and causal mediation analyses were conducted to assess the joint association of sarcopenia and reduced PEF with all‐cause mortality.
Results
During a mean follow‐up of 8.64 years, 1536 deaths were recorded. After multivariable adjustment, the hazard ratios (HRs) for mortality were 1.51 (95% CI: 1.33–1.71) for possible sarcopenia and 1.67 (95% CI: 1.43–1.94) for diagnosed sarcopenia. A dose‐dependent association between PEF and mortality was observed ( p ‐nonlinearity > 0.05). The adjusted HRs per 1‐SD decrease in PEF were 1.29 (95% CI: 1.18–1.41), 1.15 (95% CI: 1.03–1.29), and 1.49 (95% CI: 1.30–1.71) among individuals with nonsarcopenia, possible sarcopenia, and diagnosed sarcopenia, respectively ( p interaction = 0.127). Causal mediation analysis demonstrated a bidirectional mediation effect, with both natural direct and indirect effects being statistically significant. Diagnosed sarcopenia was associated with excess mortality partly mediated by reduced PEF (total effect HR: 1.63, 95% CI: 1.38–1.92; natural indirect effect HR: 1.10, 95% CI: 1.07–1.14; proportion mediated: 18.5%). Conversely, sarcopenia mediated 10.0% and 7.0% of the reduced PEF–mortality pathway for possible and diagnosed sarcopenia, respectively. Compared with participants who had normal PEF and no sarcopenia, the adjusted HRs (95% CIs) for mortality were 1.52 (1.22–1.89) for possible sarcopenia with normal PEF, 1.73 (1.28–2.35) for diagnosed sarcopenia with normal PEF, 1.60 (1.36–1.88) for impaired PEF without sarcopenia, 2.22 (1.87–2.64) for impaired PEF with possible sarcopenia, and 2.44 (2.01–2.97) for impaired PEF with diagnosed sarcopenia. No significant risk heterogeneity was observed across sex, age or lifestyle subgroups.
Conclusions
Sarcopenia and impaired respiratory function are interrelated and jointly elevate mortality risk in middle‐aged and older Chinese adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency, Shantou Central Hospital, Shantou, Guangdong, China.
- Shantou University Medical College, Shantou, Guangdong, China.
- Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
- Centre for Precision Health, Edith Cowan University School of Medical and Health Sciences, Perth, Joondalup, Australia.
- Department of Neurosurgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
- Department of Rheumatology and Immunology, Shantou Central Hospital, Shantou, Guangdong, China.
ORCID-Profile: Yulong Lan
Förderung
- Natural Science Foundation of China
- Zhongnanshan Medical Foundation of Guangdong
- Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province
- Shantou Science and Technology Plan Project, Medical and Health Category
- National Natural Science Foundation of China
Zitieren
APA
Wu, C., Wu, D., Li, M., Lu, S., Wang, Y., & Lan, Y. (2026). Combined Effect of Sarcopenia and Impaired Respiratory Function on All‐Cause Death: A Nationwide Cohort Study. Journal of Cachexia, Sarcopenia and Muscle, 17(2). https://doi.org/10.1002/jcsm.70275
Vancouver
Wu C, Wu D, Li M, Lu S, Wang Y, Lan Y. Combined Effect of Sarcopenia and Impaired Respiratory Function on All‐Cause Death: A Nationwide Cohort Study. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(2). doi:10.1002/jcsm.70275
BibTeX
@article{Wu2026,
author = {Wu, Chutao and Wu, Dan and Li, Mu and Lu, Senrong and Wang, Yukai and Lan, Yulong},
title = {Combined Effect of Sarcopenia and Impaired Respiratory Function on All‐Cause Death: A Nationwide Cohort Study},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2026},
volume = {17},
number = {2},
doi = {10.1002/jcsm.70275}
}
EUVIMED